Literature DB >> 25287458

Fragile X syndrome: a review of associated medical problems.

Sharon A Kidd1, Ave Lachiewicz2, Deborah Barbouth3, Robin K Blitz4, Carol Delahunty5, Dianne McBrien6, Jeannie Visootsak7, Elizabeth Berry-Kravis8.   

Abstract

Fragile X syndrome (FXS) is the most common known genetic cause of inherited intellectual disability and the most common known single-gene cause of autism spectrum disorder. It has been reported that a spectrum of medical problems are commonly experienced by people with FXS, such as otitis media, seizures, and gastrointestinal problems. Previous studies examining the prevalence of medical problems related to FXS have been challenging to interpret because of their marked differences in population, setting, and sampling. Through this comprehensive review, we update the literature by reviewing studies that have reported on prominent medical problems associated with FXS. We then compare prevalence results from those studies with results from a large cross-sectional database consisting of data collected by fragile X clinics that specialize in the care of children with FXS and are part of the Fragile X Clinical and Research Consortium. It is vital for pediatricians and other clinicians to be familiar with the medical problems related to FXS so that affected patients may receive proper diagnosis and treatment; improved care may lead to better quality of life for these patients and their families.
Copyright © 2014 by the American Academy of Pediatrics.

Entities:  

Keywords:  fragile X syndrome; gastrointestinal; growth; otitis media; review; seizures; sleep; strabismus

Mesh:

Year:  2014        PMID: 25287458     DOI: 10.1542/peds.2013-4301

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  70 in total

Review 1.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

2.  Assessment of efficacy of prenatal genetic diagnosis for fragile X syndrome using nested PCR.

Authors:  Zhengyou Miao; Xiaodan Liu; Weiwei Li; Qunyan He; Xia Liu
Journal:  Exp Ther Med       Date:  2018-04-13       Impact factor: 2.447

Review 3.  Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops.

Authors:  Caitlin Mullins; Gord Fishell; Richard W Tsien
Journal:  Neuron       Date:  2016-03-16       Impact factor: 17.173

4.  White Matter Alterations in Fmr1 Knockout Mice during Early Postnatal Brain Development.

Authors:  Da Shi; Su Xu; Jiachen Zhuo; Mary C McKenna; Rao P Gullapalli
Journal:  Dev Neurosci       Date:  2020-04-29       Impact factor: 2.984

5.  Autism Spectrum Disorder Symptoms in Infants with Fragile X Syndrome: A Prospective Case Series.

Authors:  Abigail L Hogan; Kelly E Caravella; Jordan Ezell; Lisa Rague; Kimberly Hills; Jane E Roberts
Journal:  J Autism Dev Disord       Date:  2017-06

6.  Opposing Post-transcriptional Control of InR by FMRP and LIN-28 Adjusts Stem Cell-Based Tissue Growth.

Authors:  Arthur Luhur; Kasun Buddika; Ishara Surangi Ariyapala; Shengyao Chen; Nicholas Samuel Sokol
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

7.  Metformin as targeted treatment in fragile X syndrome.

Authors:  A B C Dy; F Tassone; M Eldeeb; M J Salcedo-Arellano; N Tartaglia; R Hagerman
Journal:  Clin Genet       Date:  2017-09-25       Impact factor: 4.438

8.  Detailed assessment of incontinence in boys with fragile-X-syndrome in a home setting.

Authors:  Justine Niemczyk; Alexander von Gontard; Monika Equit; Katharina Bauer; Teresa Naumann; C Wagner; Leopold Curfs
Journal:  Eur J Pediatr       Date:  2016-08-27       Impact factor: 3.183

Review 9.  RNA-binding proteins implicated in neurodegenerative diseases.

Authors:  Mark R Cookson
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-09-23       Impact factor: 9.957

Review 10.  Fragile X syndrome: A review of clinical management.

Authors:  Reymundo Lozano; Atoosa Azarang; Tanaporn Wilaisakditipakorn; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.